These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 14462961
1. Studies of inhibitory effects of terephthalanilide derivatives against several variants of leukemia L1210. LAW LW. Cancer Chemother Rep; 1962 Jun; 19():13-8. PubMed ID: 14462961 [No Abstract] [Full Text] [Related]
2. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants. VENDITTI JM, GOLDIN A, KLINE I. Cancer Chemother Rep; 1962 Jun; 19():5-11. PubMed ID: 13925303 [No Abstract] [Full Text] [Related]
3. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice. VENDITTI JM, GOLDIN A, KLINE I. Cancer Chemother Rep; 1961 Apr; 11():73-6. PubMed ID: 13780696 [No Abstract] [Full Text] [Related]
5. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. II. GOLDIN A, VENDITTI JM, KLINE I, MANTEL N. Cancer Res; 1960 Jun; 20(5)Pt 2():382-469. PubMed ID: 13850662 [No Abstract] [Full Text] [Related]
7. DISTRIBUTION AND EFFECTS OF 4', 4"-DI(2-IMIDAZOLIN-2-YL)TEREPHTHALANILIDE DIHYDROCHLORIDE HEMIHYDRATE AND ITS 2-CHLORO ANALOGUE IN LYMPHOCYTIC LEUKEMIAS L1210 AND P388. SIVAK A, ROGERS WI, WODINSKY I, KENSLER CJ. J Natl Cancer Inst; 1964 Sep; 33():457-65. PubMed ID: 14207856 [No Abstract] [Full Text] [Related]
10. PREVENTION OF ANTILEUKEMIC EFFECT OF TEREPHTHALANILIDE DERIVATIVES IN TRANSPLANTED MOUSE LEUKEMIA P815 BY 4,4'-(TEREPHTHALOYLDIIMINO)DIBENZENESULFONIC ACID DISODIUM SALT (NSC-55156). BURCHENAL JH, PURPLE JR, SPOONER EB, BERCHTOLD R, HIRT R, FISCHER R, BALSIGER R. Cancer Chemother Rep; 1964 Dec; 43():5-10. PubMed ID: 14250654 [No Abstract] [Full Text] [Related]
11. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS. BURCHENAL JH, OETTGEN HF, LYMAN M, PURPLE J. Acta Unio Int Contra Cancrum; 1964 Dec; 20():256-9. PubMed ID: 14151900 [No Abstract] [Full Text] [Related]
12. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210. Schrecker AW, Goldin A. Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067 [No Abstract] [Full Text] [Related]
13. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE. BRADNER WT, BACHMAN S, PINDELL MH. Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273 [No Abstract] [Full Text] [Related]
16. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. SKIPPER HE, SCHABEL FM, WILCOX WS. Cancer Chemother Rep; 1964 Feb; 35():1-111. PubMed ID: 14117037 [No Abstract] [Full Text] [Related]
20. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia. LANE M. J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]